YU264480A - Process for obtaining the p-biphenylester of 11,15-bis-(tetrahydropyran-5-yloxy)-16-substituted tetranorprostadienic acid - Google Patents

Process for obtaining the p-biphenylester of 11,15-bis-(tetrahydropyran-5-yloxy)-16-substituted tetranorprostadienic acid

Info

Publication number
YU264480A
YU264480A YU02644/80A YU264480A YU264480A YU 264480 A YU264480 A YU 264480A YU 02644/80 A YU02644/80 A YU 02644/80A YU 264480 A YU264480 A YU 264480A YU 264480 A YU264480 A YU 264480A
Authority
YU
Yugoslavia
Prior art keywords
tetranorprostadienic
biphenylester
tetrahydropyran
yloxy
bis
Prior art date
Application number
YU02644/80A
Inventor
Johnson Michael Ross
Michael Ross Johnson
Schaaf Thomas Ken
Thomas Ken Schaaf
Bindra Jasjit Singh
Jasjit Singh Bindra
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU264480A publication Critical patent/YU264480A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
YU02644/80A 1972-11-08 1980-10-15 Process for obtaining the p-biphenylester of 11,15-bis-(tetrahydropyran-5-yloxy)-16-substituted tetranorprostadienic acid YU264480A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481572A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
YU264480A true YU264480A (en) 1983-04-27

Family

ID=23178143

Family Applications (2)

Application Number Title Priority Date Filing Date
YU02879/73A YU287973A (en) 1972-11-08 1973-11-07 Process for obtaining new p-biphenyl esters of 15-substituted omega-pentano prostaglandins
YU02644/80A YU264480A (en) 1972-11-08 1980-10-15 Process for obtaining the p-biphenylester of 11,15-bis-(tetrahydropyran-5-yloxy)-16-substituted tetranorprostadienic acid

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU02879/73A YU287973A (en) 1972-11-08 1973-11-07 Process for obtaining new p-biphenyl esters of 15-substituted omega-pentano prostaglandins

Country Status (24)

Country Link
JP (1) JPS5644068B2 (en)
AR (2) AR204816A1 (en)
AT (1) AT347607B (en)
BE (1) BE807047A (en)
CA (1) CA1027559A (en)
CH (1) CH601222A5 (en)
CS (1) CS188175B2 (en)
DD (2) DD113211A5 (en)
DE (2) DE2355042A1 (en)
ES (2) ES420326A1 (en)
FI (1) FI58116C (en)
FR (2) FR2205339B1 (en)
GB (1) GB1456511A (en)
HU (2) HU171945B (en)
IE (1) IE39686B1 (en)
IL (1) IL43553A (en)
IN (1) IN139905B (en)
NL (1) NL7315240A (en)
NO (2) NO145437C (en)
PH (2) PH15504A (en)
SE (2) SE420198B (en)
SU (2) SU538659A3 (en)
YU (2) YU287973A (en)
ZA (1) ZA738593B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2361410A1 (en) * 1972-07-13 1978-03-10 Pfizer DIALKYL ALKYLPHOSPHONATES, USEFUL AS PROSTAGLANDIN SYNTHESIS INTERMEDIARIES
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
US3998869A (en) * 1974-11-14 1976-12-21 The Upjohn Company Substituted anilide esters of 16-substituted PGE2
DE2737807A1 (en) * 1976-08-27 1978-03-09 Pfizer C LOW 1 -P-BIPHENYLESTER OF OMEGA-PENTANORPROSTAGLANDINES
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
DD113211A5 (en) 1975-05-20
CH601222A5 (en) 1978-06-30
DE2355042A1 (en) 1974-05-22
HU171945B (en) 1978-04-28
FR2205339B1 (en) 1980-01-04
FI58116C (en) 1980-12-10
FR2275452A1 (en) 1976-01-16
SE7704369L (en) 1977-04-15
IL43553A (en) 1979-10-31
NO146280B (en) 1982-05-24
IE39686L (en) 1974-05-08
IN139905B (en) 1976-08-14
NO146280C (en) 1982-09-01
NO145437B (en) 1981-12-14
CA1027559A (en) 1978-03-07
FR2275452B1 (en) 1977-12-16
HU171818B (en) 1978-03-28
AT347607B (en) 1979-01-10
FR2205339A1 (en) 1974-05-31
SE420198B (en) 1981-09-21
NO743588L (en) 1974-05-09
AR202311A1 (en) 1975-05-30
PH15504A (en) 1983-02-03
FI58116B (en) 1980-08-29
ES420326A1 (en) 1976-03-16
PH13794A (en) 1980-10-01
IE39686B1 (en) 1978-12-06
ES434687A1 (en) 1976-12-16
SU538659A3 (en) 1976-12-05
AR204816A1 (en) 1976-03-05
NL7315240A (en) 1974-05-10
AU6222573A (en) 1975-05-08
DE2365999A1 (en) 1977-05-12
GB1456511A (en) 1976-11-24
CS188175B2 (en) 1979-02-28
JPS49100060A (en) 1974-09-20
SU1021340A3 (en) 1983-05-30
NO145437C (en) 1982-03-24
ATA937173A (en) 1978-05-15
BE807047A (en) 1974-05-08
JPS5644068B2 (en) 1981-10-16
YU287973A (en) 1982-02-25
ZA738593B (en) 1974-10-30
DD111370A5 (en) 1975-02-12
IL43553A0 (en) 1974-03-14

Similar Documents

Publication Publication Date Title
ZA711010B (en) Process for the production of n-(1,1,1,-trisubstituted)-methylazoles
YU37113B (en) Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine
CH614188A5 (en) Process for the preparation of novel aminophenylethanolamines
CA1023766A (en) Process for the production of 3-halogen- and 3,5-dihalogen-phenols
EG11434A (en) Process for the manufacture of n-benzhydryl-n-p-hydroxybenzyl-piperazines
YU62671A (en) Process for preparing 7 beta-(d-5-amino-5-carboxyvaleramido)-3-(carbamoyloxy-methyl)-7-methoxy-3-cephem-4-carboxylic acid
GB1400485A (en) Process for the manufacture of 8-oxo-5-thia-1-azabicyclo- 4,2,0-oct-2-ene or -3-ene compounds
IL41815A (en) Process for the production of 2,5-dichloro-3-nitro-benzoic acid
HK62977A (en) Process for the manufacture of triacetone-amine
YU264480A (en) Process for obtaining the p-biphenylester of 11,15-bis-(tetrahydropyran-5-yloxy)-16-substituted tetranorprostadienic acid
GB1400962A (en) Process for the production of 2,4-dihydroxy-benzophenone
ZA713768B (en) Process for the manufacture of 1,1,2,2-tetrahydroperfluoro-alkanols
YU36958B (en) Process for obtaining n5-methyl-tetrahydro-homofolic acid
IL43478A0 (en) Process for the manufacture of 9,10-seco-oestrane derivatives
YU39457B (en) Process for the manufacture of herbicidal 1,2-dialkyl-3,5-diphenylpirazole salts
YU19073A (en) Process for the manufacture of cyanoalkylaminopropanes
PH9700A (en) A process for the manufacture of 20beta-hydroxy-9-oxo-1,2,3,4,10,19-hexanor-5,9-seco-pregnan-5-oic acid
GB1405218A (en) Process for the manufacture of 2-aryl-v-triazoles
IL43123A0 (en) Process for the manufacture of 7-amino-3-cephem-4-carboxylic acid derivatives
GB1407381A (en) Process for the manufacture of 2,2-anhydro-1beta-d-arabino furanosyl-5-fluoroctosine
YU110072A (en) Process for preparing acetylamine derivatives of 2,4,6-tri-iodo-benzoic acid
YU36734B (en) Process for preparing 7-amino-3-zs-(1,2,3-triazole-5-yl)-thiomethylc-3-cephem-4-carboxylic acid
GB1522142A (en) Process for the production of 2,3-dihydrobenzofurans
IL43477A0 (en) Process for the manufacture of 9,10-seco-oestrane derivatives
CA895304A (en) Process for the manufacture of 1,2-dihydrobenzodiazepines